METHOD FOR TREATING DYSTROPHIC CORNEAL DISEASES AND CORNEA TRANSPLANTATION DISEASES

摘要

medicine. SUBSTANCE: method involves administering intramuscular injections of Dalargin preparation at a dose of 3 mg during 10 days in combination with intravenous administration of 10% Perfluoran emulsion. Premedication including 1.0 ml of Relanium and 65 mg of hydrocortisone is carried out 10-15 min before administering Perfluoran emulsion. Then wet oxygen is administered for breathing through mask in a flow of 6 l/min discharge rate. 10% Perfluoran emulsion is administered after testing allergic response at a rate of 40 drops per 1 min. No allergic response being observed, the rate is increased to 60 drops per 1 min. Oxygen supply is continued during the whole procedure of Perfluoran emulsion administration. 100 ml of Perfluoran emulsion is given during one session. Then Perfluoran emulsion administration is repeated 1-3 days later. EFFECT: stable clinical effectiveness.